Immunohistochemistry Helps ID Risk for Hepatocellular Cancer
A new research paper “Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer” was published.
Read MorePosted by Chris Wolski | Aug 23, 2022 | Unknown Origin & Other Cancer Types |
A new research paper “Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer” was published.
Read MorePosted by Andy Lundin | Aug 19, 2022 | Lung Cancer |
A new collaborative project has successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva.
Read MorePosted by Andy Lundin | Aug 18, 2022 | Company News, Infectious Diseases |
Quest Diagnostics launched an obstetrics lab test panel that enables physicians to screen pregnant people easily & reliably for hepatitis C.
Read MorePosted by Andy Lundin | Aug 18, 2022 | Molecular Diagnostics |
Elevated blood levels of a certain chemokine that promotes osteoclast formation were linked with a higher risk of hip fracture in men.
Read MorePosted by Andy Lundin | Aug 17, 2022 | Emerging & Zoonotic Diseases |
Chembio Diagnostics, a POC diagnostics company focused on infectious diseases, is evaluating the potential to develop a monkeypox test.
Read More